(2S,2R,Cis)-saxagliptin

CAS : 1564265-94-6

Ref. 3D-PMC26594

Informations sur le produit

• Nom: (2S,2R,Cis)-saxagliptin
• Marque: Biosynth
• Description: (2S,2R,Cis)-saxagliptin is a drug product that has been developed for the treatment of type II diabetes. It is an orally active DPP-4 inhibitor that inhibits the degradation of GLP-1 and GIP and lowers blood glucose levels in patients with type II diabetes mellitus. It binds to the serine/threonine protein phosphatase catalytic site of DPP-4. (2S,2R,Cis)-saxagliptin can be used as a standard for HPLC analysis and as a research and development compound in the study of its metabolism. This drug product is not on the World Health Organization's list of essential medicines. (2S,2R,Cis)-saxagliptin is also not on the United States Pharmacopeia’s list of approved drugs.

Propriétés chimiques

• Masse moléculaire: 315.40 g/mol
• Formule: C₁₈H₂₅N₃O₂
• Degré de pureté: Min. 95%